Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("endostatin")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 355

  • Page / 15
Export

Selection :

  • and

Endostatin expression in a pancreatic cell line is modulated by a TNFα-dependent elastaseBRAMMER, R. D; BRAMHALL, S. R; EGGO, M. C et al.British journal of cancer. 2005, Vol 93, Num 9, pp 1024-1028, issn 0007-0920, 5 p.Article

Low levels of endostatin in the urine from patients with malignant diseaseLINDER-STRAGLIOTTO, Christina; STRANDER, Hans; MUNCK-WIKLAND, Eva et al.Tumor biology. 2002, Vol 23, Num 4, pp 222-227, issn 1010-4283, 6 p.Article

Linking Antibody Fc Domain to Endostatin Significantly Improves Endostatin Half-life and EfficacyLEE, Tong-Young; SJIN, Robert M. Tjintham; MOVAHEDI, Shahla et al.Clinical cancer research. 2008, Vol 14, Num 5, pp 1487-1493, issn 1078-0432, 7 p.Article

VEGF expression in adult permanent thyroid cartilage: implications for lack of cartilage ossification : Fractures in osteoporosisPUFE, Thomas; MENTLEIN, Rolf; TSOKOS, Michael et al.Bone (New York, NY). 2004, Vol 35, Num 2, pp 543-552, issn 8756-3282, 10 p.Article

Endostatin and Physical Exercise in Young Female and Male Athletes and ControlsSPONDER, M; SEPTOL, K; LANKISCH, S et al.International journal of sports medicine. 2014, Vol 35, Num 13, pp 1138-1142, issn 0172-4622, 5 p.Article

Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumorsLI, H.-L; LI, S; GUAN, Z.-Z et al.Gene therapy (Basingstoke). 2008, Vol 15, Num 4, pp 247-256, issn 0969-7128, 10 p.Article

Statin-AE: A novel angiostatin-endostatin fusion protein with enhanced antiangiogenic and antitumor activitySCAPPATICCI, Frank A; CONTRERAS, Anthony; SMITH, Richard et al.Angiogenesis (London). 2001, Vol 4, Num 4, pp 263-268, issn 0969-6970Article

Antiangiogenesis Effects of Endostatin in Retinal NeovascularizationBAI, Yu-Jing; HUANG, Lv-Zhen; ZHOU, Ai-Yi et al.Journal of ocular pharmacology and therapeutics. 2013, Vol 29, Num 7, pp 619-626, issn 1080-7683, 8 p.Article

The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularizationOLSSON, Anna-Karin; JOHANSSON, Irja; AKERUD, Helena et al.Cancer research (Baltimore). 2004, Vol 64, Num 24, pp 9012-9017, issn 0008-5472, 6 p.Article

Therapeutic efficacy of endostatin exhibits a biphasic dose-response curveCELIK, Ilhan; SÜRÜCÜ, Oguzkan; DIETZ, Carsten et al.Cancer research (Baltimore). 2005, Vol 65, Num 23, pp 11044-11050, issn 0008-5472, 7 p.Article

Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. CommentaryFOLKMAN, Judah; HUBING SHI; YUJIE HUANG et al.Blood. 2007, Vol 110, Num 8, issn 0006-4971, 2786-2787, 2899-2906 [10 p.]Article

Therapy of hematogenous melanoma brain metastases with endostatinKIRSCH, Matthias; WEIGEL, Patrick; PINZER, Thomas et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1259-1267, issn 1078-0432, 9 p.Article

Effect of thalidomide on endostatin levels in retinal ischemia/reperfusion injuryAYDOGAN, Semih; TÜRKCÜOGLU, Peykan; CELIKER, Ulkü et al.Ophthalmologica (Basel). 2007, Vol 221, Num 6, pp 418-420, issn 0030-3755, 3 p.Article

Développement clinique des traitements anti-angiogéniques en 2002 = Clinical development of anti-angiogenic agents in 2002BACHELOT, Thomas; JOUANNEAU, Emmanuel; BLAY, Jean-Yves et al.Bulletin du cancer. 2003, Vol 90, Num 1, pp 19-23, issn 0007-4551, 5 p.Article

Elevated serum concentrations of the angiogenesis inhibitor endostatin in preeclamptic womenHIRTENLEHNER, Kora; POLLHEIMER, Jürgen; LICHTENBERGER, Cornelia et al.Journal of the Society for Gynecologic Investigation. 2003, Vol 10, Num 7, pp 412-417, issn 1071-5576, 6 p.Article

Delivery of endostatin in experimental cancer therapySORENSEN, Dag R; READ, Tracy-Ann.International journal of experimental pathology. 2002, Vol 83, Num 6, pp 265-274, issn 0959-9673, 10 p.Article

Effect of methanol feeding strategies on production and yield of recombinant mouse endostatin from Pichia pastorisTRINH, L. B; PHUE, J. N; SHILOACH, Joseph et al.Biotechnology and bioengineering. 2003, Vol 82, Num 4, pp 438-444, issn 0006-3592, 7 p.Article

The antiangiogenic and therapeutic implications of endostatinREN, B; HÖTI, N; RABASSEDA, X et al.Methods and findings in experimental and clinical pharmacology. 2003, Vol 25, Num 3, pp 215-224, issn 0379-0355, 10 p.Article

Effect of CDT6 on factors of angiogenic balance in tumour cell linesBOUÏS, Diane R. M. H; DAM, Wendy A; MEIJER, Coby et al.Anticancer research. 2007, Vol 27, Num 4B, pp 2325-2329, issn 0250-7005, 5 p.Article

Antiangiogenic treatment with endostatin inhibits progression of AML in vivoSCHUCH, G; OLIVEIRA-FERRER, L; LOGES, S et al.Leukemia. 2005, Vol 19, Num 8, pp 1312-1317, issn 0887-6924, 6 p.Article

Serum endostatin levels in patients with epithelial ovarian cancerHATA, Kohkichi; DIPOK KUMAR DHAR; KANASAKI, Haruhiko et al.Anticancer research. 2003, Vol 23, Num 2C, pp 1907-1912, issn 0250-7005, 6 p.Article

Serum endostatin levels in gastric cancer patients : Correlation with clinicopathological parametersKOC, Mahmut; GÖCMEN, Erdal; KILIC, Mehmet et al.Hepato-gastroenterology. 2006, Vol 53, Num 70, pp 616-618, issn 0172-6390, 3 p.Article

A high risk of occurrence of sporadic breast cancer in individuals with the 104NN polymorphism of the COL18A1 geneLOURENCO, Gustavo J; CARDOSO-FILHO, Cassio; GONCALES, Neiva S. L et al.Breast cancer research and treatment. 2006, Vol 100, Num 3, pp 335-338, issn 0167-6806, 4 p.Article

N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agentCHO, Heeyeong; WOO JEAN KIM; YOU MIE LEE et al.Oncology reports. 2004, Vol 11, Num 1, pp 191-195, issn 1021-335X, 5 p.Article

Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment : Mode of drug delivery and clearance rate dependenciesTEE, Daniel; DISTEFANO, Joseph III.Journal of cancer research and clinical oncology. 2004, Vol 130, Num 1, pp 15-24, issn 0171-5216, 10 p.Article

  • Page / 15